Tag: bimekizumab

Ucb: Positive phase 3 results for bimekizumab

Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…

UCB: positive phase 3 results for bimekizumab

(CercleFinance.com) – The Belgian pharmaceutical group UCB announced on Friday that bimekizumab had shown its efficacy in two phase 3 clinical studies devoted to the treatment of hidradenitis suppurativa, a…

UCB: the stock outperforms, success for bimekizumab

(CercleFinance.com) – UCB shares outperformed on the Brussels Stock Exchange on Friday following the publication of positive results on bimekizumab in the treatment of psoriatic arthritis. The title is currently…